{
  "main_header": {
    "sid": 10039387,
    "name": "Sanofi Consumer",
    "stock_name": "Sanofi Consumer",
    "full_name": "Sanofi Consumer Healthcare India Ltd",
    "name_url": "stocks-analysis/sanofi-consumer",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,505.90",
    "chg": 1.8,
    "chgp": "0.04%",
    "dir": 1,
    "prev_price": "4,504.10",
    "mcapval": "10,318.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544250,
    "symbol": "SANOFICONR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0UOS01011",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "3.77 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/sanofi-consumer-10039387-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sanofi Consumer Healthcare India Ltd Upgraded to Hold on Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanofi-consumer-healthcare-india-ltd-upgraded-to-hold-on-technical-and-financial-improvements-3998447",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanofiConsumerH_mojoScore_3998447.png",
        "date": "2026-05-19 09:09:09",
        "description": "Sanofi Consumer Healthcare India Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by an improved technical outlook and positive financial trends. The company’s robust quarterly results, strong management efficiency, and net-debt-free status have contributed to this reassessment, despite some concerns over valuation and long-term growth. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the recent rating change."
      },
      {
        "title": "Sanofi Consumer Healthcare India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sanofi-consumer-healthcare-india-ltd-is-rated-sell-3989262",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/SanofiConsumerH_mojoScore_3989262.png",
        "date": "2026-05-13 10:10:52",
        "description": "Sanofi Consumer Healthcare India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 11 May 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 13 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 15,
    "sid": "10039387",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/sanofi-consumer-healthcare-india-10039387"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Jul-2026",
      "details": "Copy of Newspaper Publication of Unaudited Financial Results for the quarter and half year ended 30th June 2026 is enclosed.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "28-Jul-2026",
      "details": "The Board of Directors at its meeting held on Tuesday 28th July 2026 considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2026. In this regard please find enclosed a press release.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 28Th July 2026",
      "datetime": "28-Jul-2026",
      "details": "We wish to inform you that the Board of Directors at its meeting held today i.e. Tuesday 28th July 2026 inter alia considered and approved the Unaudited Financial Results for the quarter and half year ended 30th June 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sanofi Consumer Healthcare India Ltd has declared <strong>750%</strong> dividend, ex-date: 19 Jun 26",
          "dt": "2026-06-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sanofi Consumer Healthcare India Ltd Upgraded to Hold on Technical and Financial Improvements

2026-05-19 09:09:09

Sanofi Consumer Healthcare India Ltd has seen its investment rating upgraded from Sell to Hold, driven primarily by an improved technical outlook and positive financial trends. The company’s robust quarterly results, strong management efficiency, and net-debt-free status have contributed to this reassessment, despite some concerns over valuation and long-term growth. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced the recent rating change.

Read More

Sanofi Consumer Healthcare India Ltd is Rated Sell

2026-05-13 10:10:52

Sanofi Consumer Healthcare India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 11 May 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 13 May 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read More

View All News